Hosted on MSN14d
Eli Lilly projects 32% revenue growth for 2025, fueled by incretin expansion and new launchesEarnings Call Insights: Eli Lilly and Company (NYSE ... the initiation of new Phase 3 programs for promising assets. CFO Lucas Montarce reported a gross margin increase to 83.2%, driven by ...
"so that's what we built in our 2025 guidance for the market," the company's CFO Lucas Montarce said during an earnings call on Thursday. Shares of Eli Lilly rose more than 4% on Thursday.
David Ricks; Chairman of the Board, President, Chief Executive Officer; Eli Lilly and Co Lucas Montarce; Executive Vice President and Chief Financial Officer; Eli Lilly and Co Daniel Skovronsky ...
9, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the appointment of Lucas Montarce as executive vice president and chief financial officer (CFO) and member of the company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results